The study by the University of Oxford’s Department of Oncology and Kennedy Institute, published in the International Journal of Cancer, found that if pancreatic cancer patients had higher levels of T-cells - a type of white blood cell that plays a key role in a body’s immune response – in their cancer, they would live longer after an operation. Pancreatic cancer is an aggressive cancer and currently has limited treatment options and scientists believe these findings may lead to the investigation of new treatments. Read more . . .